Back
Enanta Pharmaceuticals 10K Form
Sell
11
ENTA
Enanta Pharmaceuticals
Last Price:
$5.99
Seasonality Move:
7.84%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
| 2024-05-08 | 10Q | ENTA/Enanta Pharmaceuticals Quarterly |
| 2024-02-08 | 10Q | ENTA/Enanta Pharmaceuticals Quarterly |
| 2023-08-08 | 10Q | ENTA/Enanta Pharmaceuticals Quarterly |
| 2023-05-09 | 10Q | ENTA/Enanta Pharmaceuticals Quarterly |
| 2023-02-08 | 10Q | ENTA/Enanta Pharmaceuticals Quarterly |
| 2022-08-08 | 10Q | ENTA/Enanta Pharmaceuticals Quarterly |
Receive ENTA News And Ratings
See the #1 stock for the next 7 days that we like better than ENTA
ENTA Financial Statistics
Sales & Book Value
| Annual Sales: | $67.6M |
|---|---|
| Cash Flow: | $-19.4M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $6.08 |
| Price / Book: | 1 |
Profitability
| EPS (TTM): | -5.48000 |
|---|---|
| Net Income (TTM): | $-116M |
| Gross Margin: | $0 |
| Return on Equity: | -68.07% |
| Return on Assets: | -27.9% |
Enanta Pharmaceuticals Earnings Forecast
Key Enanta Pharmaceuticals Financial Ratios
-
The Gross Profit Margin over the past 4 years for ENTA is 0.00%.
-
The Selling, General & Administrative Expenses for ENTA have been equal to 85.53% of Gross Profit Margin.
-
The Research & Development expenses have been 194.39% of Revenue.
-
The Interest Expense is -9.43% of Operating Income.
-
The Net Earning history of ENTA is -171.58% of Total Revenues.
-
Per Share Earnings over the last 15 years have been positive in 5 years.
Enanta Pharmaceuticals Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Biotechnology |
| Sector: | Health Care |
| Current Symbol: | ENTA |
| CUSIP: | 29251M |
| Website: | enanta.com |
Debt
| Debt-to-Equity Ratio: | 0 |
|---|---|
| Current Ratio: | 5.21 |
| Quick Ratio: | 4.99 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |
ENTA Technical Analysis vs Fundamental Analysis
Sell
11
Enanta Pharmaceuticals (ENTA)
is a Sell
Is Enanta Pharmaceuticals a Buy or a Sell?
-
Enanta Pharmaceuticals stock is rated a SellThe current Enanta Pharmaceuticals [ENTA] share price is $6.10. The Score for ENTA is 11, which is 78% below its historic median score of 50, and infers higher risk than normal.